Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial
Eleanor Mitchell, Rachel Quao, Titilope A. Adeyemo, Opeyemi Akinajo et al.
Citations
9 citations
Journal
BMJ Open
Topics
Iron Metabolism and Disorders
Field-Weighted Citation Impact (FWCI)
4.09
article
Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial
Eleanor Mitchell, Rachel Quao, Titilope A. Adeyemo, Opeyemi Akinajo, Yewande Oshodi, Victoria Olawunmi Adaramoye, Mobolanle Balogun, Bosede Bukola Afolabi, Aduragbemi Oluwabusayo Banke-Thomas, Folasade Ogunsola, Kate F. Walker, Ochuwa Adiketu Babah, Ejemai Eboreime, Chisom Florence Chieme, Ibraheem Ajibola Abioye
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(8)
Institutions
Harvard University (US), University of Nottingham (GB), University of Alberta (CA), University of Lagos (NG), Lagos University Teaching Hospital (NG), London School of Hygiene & Tropical Medicine (GB), Harvard Global Health Institute (US), National Primary Health Care Development Agency (NG)